553 related articles for article (PubMed ID: 33059828)
1. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB
J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110
[TBL] [Abstract][Full Text] [Related]
3. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
[TBL] [Abstract][Full Text] [Related]
4. 5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease.
Garcia S; Cubeddu RJ; Hahn RT; Ternacle J; Kapadia SR; Kodali SK; Thourani VH; Jaber WA; Asher CR; Elmariah S; Makkar R; Webb JG; Herrmann HC; Lu M; Devireddy CM; Malaisrie SC; Smith CR; Mack MJ; Sorajja P; Cavalcante JL; Goessl M; Shroff GR; Leon MB; Pibarot P
JACC Cardiovasc Interv; 2021 Sep; 14(18):1995-2005. PubMed ID: 34556273
[TBL] [Abstract][Full Text] [Related]
5. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
[TBL] [Abstract][Full Text] [Related]
6. Bioprosthetic structural valve deterioration: How do TAVR and SAVR prostheses compare?
Aldalati O; Kaura A; Khan H; Dworakowski R; Byrne J; Eskandari M; Deshpande R; Monaghan M; Wendler O; MacCarthy P
Int J Cardiol; 2018 Oct; 268():170-175. PubMed ID: 30041783
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
11. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.
Gleason TG; Reardon MJ; Popma JJ; Deeb GM; Yakubov SJ; Lee JS; Kleiman NS; Chetcuti S; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Conte JV; Mumtaz M; Oh JK; Huang J; Adams DH;
J Am Coll Cardiol; 2018 Dec; 72(22):2687-2696. PubMed ID: 30249462
[TBL] [Abstract][Full Text] [Related]
12. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
[TBL] [Abstract][Full Text] [Related]
13. Bioprosthetic valve failure. Comparative trial of two balloon-expandable transcatheter heart valve systems in intermediate-risk patients: a propensity score analysis.
Eid-Lidt G; Vega Servín S; Farjat Pasos JI; Rivera Rodríguez A; Anaya Morales CA; Marroquin Donday LA; Nombela Franco L; Gaspar J
Acta Cardiol; 2022 Apr; 77(2):158-165. PubMed ID: 34092183
[TBL] [Abstract][Full Text] [Related]
14. Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
Sathananthan J; Lauck S; Polderman J; Yu M; Stephenson A; Sathananthan G; Moss R; Cheung A; Ye J; Blanke P; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2021 Feb; 97(3):E431-E437. PubMed ID: 32940418
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
Thyregod HGH; Jørgensen TH; Ihlemann N; Steinbrüchel DA; Nissen H; Kjeldsen BJ; Petursson P; De Backer O; Olsen PS; Søndergaard L
Eur Heart J; 2024 Apr; 45(13):1116-1124. PubMed ID: 38321820
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB
Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442
[TBL] [Abstract][Full Text] [Related]
17. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of structural valve deterioration and bioprosthetic valve failure utilizing the new European consensus definition in patients undergoing TAVI with first-generation devices: Outcomes beyond 5 years from a single center in Turkey.
Şentürk B; Dursun H; Çöllüoğlu T; Özdamar H; Ekin T; Tanrıverdi Z; Kaya D
Anatol J Cardiol; 2021 Aug; 25(8):579-587. PubMed ID: 34369886
[TBL] [Abstract][Full Text] [Related]
19. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
[TBL] [Abstract][Full Text] [Related]
20. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
